A Study of Calderasib (MK-1084) in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017)

Clinical trial NCT07219550 · COMPLETED

Trial details

NCT number: NCT07219550
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Hepatic Impairment

Start date: 2025-11-05
Primary completion: 2026-07-15
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.